Overall, it has been shown that mucosal vaccines elicit CD4 TRM cells in the genital tracts of mice and that these cells likely contribute to accelerated resolution of chlamydial infection upon challenge. This evidence concerns the gene CD4 and chlamydia trachomatis infectious disease.